AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32616452 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Empowerment Education (My Asthma Therapeutic Education)
Number of subjects: 37
Study 32616452 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 32241898 — intervention group
Group type: EXPERIMENTAL
Intervention: 2G-NBI
Number of subjects: 4523
Study 32241898 — intervention group
Group type: COMPARATOR
Intervention: WLI
Number of subjects: 4523
Study 34321133 — intervention group
Group type: EXPERIMENTAL
Intervention: Health harms awareness
Number of subjects: 544
Study 34321133 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental harms awareness
Number of subjects: 544
Study 34321133 — intervention group
Group type: EXPERIMENTAL
Intervention: Discouragement from health harms
Number of subjects: 544
Study 34321133 — intervention group
Group type: EXPERIMENTAL
Intervention: General perceptions and demographics
Number of subjects: 544
Study 33657531 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-EX (30-minute cognitive task followed by a 15-minute high-intensity interval exercise bout)
Number of subjects: 19
Study 33657531 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-CD (30-minute cognitive task performed on a cycling desk)
Number of subjects: 19
Study 33657531 — intervention group
Group type: COMPARATOR
Intervention: CON (resting session)
Number of subjects: 19
Study 33657531 — intervention group
Group type: EXPERIMENTAL
Intervention: CT (30-minute cognitive task)
Number of subjects: 19
Study 33942212 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mM citrate buffer
Number of subjects: 0
Study 33942212 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mM citrate buffer
Number of subjects: 0
Study 33942212 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mM citrate buffer
Number of subjects: 0
Study 33942212 — intervention group
Group type: EXPERIMENTAL
Intervention: NaCl and propylene glycol
Number of subjects: 0
Study 33942212 — intervention group
Group type: EXPERIMENTAL
Intervention: Histidine buffers (150 mM, 75 mM, 25 mM, 0 mM NaCl)
Number of subjects: 0
Study 33942212 — intervention group
Group type: EXPERIMENTAL
Intervention: Histidine buffers containing Arginine‐HCl (0, 50, or 150 mM)
Number of subjects: 0
Study 33942212 — intervention group
Group type: EXPERIMENTAL
Intervention: Histidine buffer at pH 6.5
Number of subjects: 0
Study 32015415 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention (specifics not provided)
Number of subjects: 0
Study 34911168 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-interruptive alert in the ordering IT-system
Number of subjects: 313
Study 34911168 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruptive alert in the ordering IT-system
Number of subjects: 313
Study 34911168 — intervention group
Group type: COMPARATOR
Intervention: Guidelines alone
Number of subjects: 313
Study 34911168 — intervention group
Group type: COMPARATOR
Intervention: Guidelines combined with feedback reports
Number of subjects: 313
Study 34911168 — intervention group
Group type: COMPARATOR
Intervention: Monthly feedback reports
Number of subjects: 313
Study 34911168 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of alerts and feedback reports
Number of subjects: 313
Study 34204017 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingual laser frenectomy using a diode laser (power 7 W)
Number of subjects: 32
Study 34204017 — intervention group
Group type: COMPARATOR
Intervention: Control group with myofunctional and speech therapy
Number of subjects: 32
Study 34441773 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading protocol using VulkanLoc® abutments after implant emplacement
Number of subjects: 20
Study 34441773 — intervention group
Group type: COMPARATOR
Intervention: Conventional loading protocol with VulkanLoc® abutments connected two months after surgery
Number of subjects: 20
Study 35298997 — intervention group
Group type: COMPARATOR
Intervention: Emotion regulation task during fMRI scanning in rrMDD patients
Number of subjects: 70
Study 35298997 — intervention group
Group type: COMPARATOR
Intervention: Explicit downregulation of negative emotions
Number of subjects: 70
Study 35298997 — intervention group
Group type: COMPARATOR
Intervention: Explicit upregulation of positive emotions
Number of subjects: 70
Study 35298997 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily life regulation strategies
Number of subjects: 70
Study 35298997 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination in rrMDD patients
Number of subjects: 70
Study 33368969 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoxifen (8 mg daily)
Number of subjects: 116
Study 32612272 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical activity
Number of subjects: 833
Study 32612272 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous physical activity
Number of subjects: 833
Study 32612272 — intervention group
Group type: COMPARATOR
Intervention: Light physical activity
Number of subjects: 833
Study 35688247 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysinibacillus fusiformis strain Lf (ureolytic bacteria)
Number of subjects: 0
Study 35688247 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 35164695 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training intervention (IMPETUS-D) for nursing home staff
Number of subjects: 1304
Study 35164695 — intervention group
Group type: COMPARATOR
Intervention: Usual training opportunities for nursing home staff (Control)
Number of subjects: 1304
Study 34726650 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention by postpartum nurse navigator (PPNN)
Number of subjects: 43
Study 32965505 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic index model for treatment outcome
Number of subjects: 61
Study 32965505 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic index model for post-treatment participation
Number of subjects: 61
Study 32965505 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-validated prognostic index scores
Number of subjects: 61
Study 35327700 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental storybook intervention
Number of subjects: 88
Study 35327700 — intervention group
Group type: COMPARATOR
Intervention: Control group (no storybook)
Number of subjects: 88
Study 32840767 — intervention group
Group type: EXPERIMENTAL
Intervention: Local application of 2.0 g TXA in 10 mL 0.9% NaCl after suturing the joint capsule
Number of subjects: 72
Study 32840767 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of 2 g TXA in 200 mL 0.9% NaCl 30 min before the operation
Number of subjects: 72
Study 34705157 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face instruction and personalized bowel preparation regimens
Number of subjects: 320
Study 34705157 — intervention group
Group type: COMPARATOR
Intervention: Routine bowel preparation regimen and education
Number of subjects: 320
Study 33879260 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine-based medication treatment for opioid use disorder (MOUD)
Number of subjects: 0
Study 33879260 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine-based MOUD
Number of subjects: 0
Study 32227624 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness session (n = 42)
Number of subjects: 68
Study 32227624 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 26)
Number of subjects: 68
Study 34998253 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Training
Number of subjects: 42
Study 34998253 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral Training
Number of subjects: 42
Study 34998253 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 42
Study 33093222 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin
Number of subjects: 2924
Study 33093222 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 2924
Study 35947945 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear low-intensity extracorporeal shockwave therapy (LI-LiESWT) using the PiezoWave2 device with a linear shockwave applicator, administered over 4 treatments in a 4-week period.
Number of subjects: 32
Study 35947945 — intervention group
Group type: COMPARATOR
Intervention: Sham group (control group).
Number of subjects: 32
Study 34642416 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Therapy room
Number of subjects: 33
Study 34642416 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality room
Number of subjects: 33
Study 34642416 — intervention group
Group type: COMPARATOR
Intervention: Control room
Number of subjects: 33
Study 34642416 — intervention group
Group type: EXPERIMENTAL
Intervention: Biophilic interventions
Number of subjects: 33
Study 32986459 — intervention group
Group type: COMPARATOR
Intervention: 0 mg methamphetamine
Number of subjects: 19
Study 32986459 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg methamphetamine
Number of subjects: 19
Study 32986459 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg methamphetamine
Number of subjects: 19
Study 32986459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 32000474 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological strategy (walking through the operating room and playfully demonstrating anesthesia equipment)
Number of subjects: 43
Study 32000474 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (medication)
Number of subjects: 43
Study 32000474 — intervention group
Group type: COMPARATOR
Intervention: Medication (Midazolam)
Number of subjects: 43
Study 32000474 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological strategy
Number of subjects: 43
Study 34800178 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks plus axitinib 5 mg twice daily
Number of subjects: 94
Study 34800178 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib 50 mg once daily (4 weeks on/2 weeks off)
Number of subjects: 94
Study 34800178 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab-axitinib
Number of subjects: 94
Study 34800178 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 94
Study 32152869 — intervention group
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/18/9.6 μg
Number of subjects: 432
Study 36344929 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyclonal rabbit antithymocyte globulin (Grafalon®) 6 mg/kg/day
Number of subjects: 80
Study 36344929 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 80
Study 36344929 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyclonal rabbit antithymocyte globulin (Grafalon®)
Number of subjects: 80
Study 34106239 — intervention group
Group type: EXPERIMENTAL
Intervention: Shamiri intervention
Number of subjects: 413
Study 34106239 — intervention group
Group type: COMPARATOR
Intervention: Study skills control
Number of subjects: 413
Study 32562173 — intervention group
Group type: EXPERIMENTAL
Intervention: RJ markers (RJMs) designed from transposable elements’ repeat junctions
Number of subjects: 32
Study 32562173 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 polymorphic RJ primers
Number of subjects: 32
Study 32562173 — intervention group
Group type: EXPERIMENTAL
Intervention: UPGMA cluster analysis
Number of subjects: 32
Study 35160211 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniosacral therapy group (CTG)
Number of subjects: 50
Study 34273367 — intervention group
Group type: COMPARATOR
Intervention: MSFWs working in conventional fields
Number of subjects: 101
Study 34273367 — intervention group
Group type: EXPERIMENTAL
Intervention: MSFWs working in organic fields
Number of subjects: 101
Study 34273367 — intervention group
Group type: EXPERIMENTAL
Intervention: MSFWs (overall)
Number of subjects: 101
Study 34273367 — intervention group
Group type: EXPERIMENTAL
Intervention: MSFWs
Number of subjects: 101
Study 34257012 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of low-dose sevoflurane (end-expiratory concentration, 0.4%) through a face mask
Number of subjects: 336
Study 34257012 — intervention group
Group type: COMPARATOR
Intervention: Intranasal ketamine (2 mg/kg)
Number of subjects: 336
Study 34257012 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of low-dose sevoflurane
Number of subjects: 336
Study 32888791 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire responses from research nurses
Number of subjects: 10
Study 32888791 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-structured interviews with research nurses
Number of subjects: 10
Study 36210291 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 0
Study 36210291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33787576 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-minute CPR training cycles
Number of subjects: 62
Study 33787576 — intervention group
Group type: COMPARATOR
Intervention: 2-minute CPR training cycles (Control Group)
Number of subjects: 62
Study 32507152 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (35 Hz)
Number of subjects: 12
Study 32507152 — intervention group
Group type: COMPARATOR
Intervention: Sham group (sub-therapeutic WBV 8 Hz)
Number of subjects: 12
Study 36123817 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent care clinic model
Number of subjects: 59
Study 36123817 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional ambulatory rotation)
Number of subjects: 59
Study 32672998 — intervention group
Group type: COMPARATOR
Intervention: Withholding a PD diagnosis
Number of subjects: 328
Study 32672998 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosing a PD diagnosis (Borderline, Antisocial, Mild, Moderate, Severe)
Number of subjects: 328
Study 32163578 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure treatment (systolic BP target <120 mmHg)
Number of subjects: 9334
Study 32163578 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure treatment (systolic BP target <140 mmHg)
Number of subjects: 9334
Study 36048290 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic strengthening intervention
Number of subjects: 613
Study 36048290 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 613
Study 33148103 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg escitalopram
Number of subjects: 64
Study 32846626 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat‐killed cells of Lactobacillus rhamnosus and Lactococcus lactis
Number of subjects: 24
Study 32846626 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat‐killed cells of Saccharomyces cerevisiae
Number of subjects: 24
Study 32846626 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of LAB and yeast cells
Number of subjects: 24
Study 32846626 — intervention group
Group type: EXPERIMENTAL
Intervention: Yeast cells alone
Number of subjects: 24
Study 32846626 — intervention group
Group type: COMPARATOR
Intervention: Control (no addition of LAB or yeast cells)
Number of subjects: 24
Study 35634888 — intervention group
Group type: EXPERIMENTAL
Intervention: Home cardiac rehabilitation (home-CR)
Number of subjects: 49
Study 35634888 — intervention group
Group type: COMPARATOR
Intervention: Traditional cardiac rehabilitation (TCR)
Number of subjects: 49
Study 32482150 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting beta2 agonists (SABAs)
Number of subjects: 603000000
Study 32482150 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory reliever therapy (combination of low dose ICS/fast action bronchodilator)
Number of subjects: 603000000
Study 32434151 — intervention group
Group type: EXPERIMENTAL
Intervention: Yi Jin Jing exercise
Number of subjects: 30
Study 36459172 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical stabilization exercises (progressive home-based program)
Number of subjects: 39
Study 36459172 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 39
Study 32868662 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan (Sac/Val)
Number of subjects: 186
Study 32868662 — intervention group
Group type: COMPARATOR
Intervention: Conventional angiotensin-converting enzyme inhibitors (ACEI)
Number of subjects: 186
Study 36451452 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine combined with sufentanil (Group H)
Number of subjects: 160
Study 36451452 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine combined with sufentanil (Group M)
Number of subjects: 160
Study 36451452 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine combined with sufentanil (Group L)
Number of subjects: 160
Study 36451452 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine combined with sufentanil (Group H, Group M, Group L)
Number of subjects: 160
Study 33951140 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted individualized hemodynamic management
Number of subjects: 38
Study 33951140 — intervention group
Group type: COMPARATOR
Intervention: Manually adjusted goal-directed therapy
Number of subjects: 38
Study 32213306 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 2845
Study 32213306 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 2845
Study 32213306 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 2845
Study 32213306 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 2845
Study 32213306 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 2845
Study 35723774 — intervention group
Group type: EXPERIMENTAL
Intervention: Active remote-microphone listening device
Number of subjects: 0
Study 35723774 — intervention group
Group type: COMPARATOR
Intervention: Inactive remote-microphone listening device (placebo)
Number of subjects: 0
Study 33461966 — intervention group
Group type: EXPERIMENTAL
Intervention: iHOT‐33
Number of subjects: 0
Study 33461966 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ‐5D Visual Analogue Scale (VAS)
Number of subjects: 0
Study 32541380 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine plus 5-hydroxytryptophan (100 mg twice daily)
Number of subjects: 60
Study 32541380 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine plus placebo
Number of subjects: 60
Study 36238973 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (n = 45)
Number of subjects: 89
Study 36238973 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 44)
Number of subjects: 89
Study 33201771 — intervention group
Group type: EXPERIMENTAL
Intervention: Eravacycline 1 mg/kg intravenously every 12 hours
Number of subjects: 846
Study 33201771 — intervention group
Group type: COMPARATOR
Intervention: Carbapenem comparators (ertapenem 1 g intravenously every 24 hours or meropenem 1 g intravenously every eight hours)
Number of subjects: 846
Study 33201771 — intervention group
Group type: EXPERIMENTAL
Intervention: Eravacycline
Number of subjects: 846
Study 33201771 — intervention group
Group type: COMPARATOR
Intervention: Carbapenem comparators
Number of subjects: 846
Study 33201771 — intervention group
Group type: COMPARATOR
Intervention: Eravacycline and Carbapenem comparators
Number of subjects: 846
Study 36294062 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism Adaptation + Neck Vibration (Group A)
Number of subjects: 36
Study 36294062 — intervention group
Group type: COMPARATOR
Intervention: Neck Vibration only (Group B)
Number of subjects: 36
Study 36294062 — intervention group
Group type: COMPARATOR
Intervention: Prism Adaptation only (Group C)
Number of subjects: 36
Study 36294062 — intervention group
Group type: COMPARATOR
Intervention: All groups (PA + NV, NV only, PA only)
Number of subjects: 36
Study 32369844 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiary prophylaxis with FVIII levels at 1 IU/dL
Number of subjects: 63
Study 32369844 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiary prophylaxis with FVIII levels between 1 and 10 IU/dL
Number of subjects: 63
Study 32369844 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiary prophylaxis with FVIII levels of approximately 1 to 3 IU/dL
Number of subjects: 63
Study 34598883 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Dose-Rate (LDR) brachytherapy
Number of subjects: 816
Study 34598883 — intervention group
Group type: COMPARATOR
Intervention: High-Dose-Rate (HDR) brachytherapy
Number of subjects: 816
Study 34598883 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LDR and HDR brachytherapy
Number of subjects: 816
Study 35925503 — intervention group
Group type: EXPERIMENTAL
Intervention: TEP technique
Number of subjects: 300
Study 35925503 — intervention group
Group type: COMPARATOR
Intervention: TIPP technique
Number of subjects: 300
Study 33500115 — intervention group
Group type: EXPERIMENTAL
Intervention: Home management (n=66)
Number of subjects: 149
Study 33500115 — intervention group
Group type: COMPARATOR
Intervention: Primary care physician follow-up (n=67)
Number of subjects: 149
Study 33500115 — intervention group
Group type: EXPERIMENTAL
Intervention: Home management
Number of subjects: 149
Study 35552528 — intervention group
Group type: EXPERIMENTAL
Intervention: KarXT (xanomeline-trospium)
Number of subjects: 170
Study 35552528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study 34244280 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative antibiotic prophylaxis
Number of subjects: 0
Study 34244280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32466056 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin treatment (80 mg via nasogastric tube)
Number of subjects: 84
Study 32466056 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 84
Study 34157957 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended dairy diet plus exercise (RDa, n = 24)
Number of subjects: 63
Study 34157957 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dairy diet plus exercise (LDa, n = 25)
Number of subjects: 63
Study 34157957 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control (n = 14)
Number of subjects: 63
Study 32891136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.2 μg·kg‐1 combined with remifentanil
Number of subjects: 0
Study 32891136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.3 μg·kg‐1 combined with remifentanil
Number of subjects: 0
Study 32891136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.4 μg·kg‐1 combined with remifentanil
Number of subjects: 0